tirzepatide approval FDA confirms shortage is still over, gives compounders a grace period Tirzepatide Cuts Risk of Diabetes

Tirzepatide is now widely available as a prescription medicine made by Eli Lilly under the brands names Mounjaro (for type 2 diabetes) and Zepbound (for weight loss and sleep apnea)

It mimics the GLP-1 hormone in your intestine, which boosts insulin release, reduces blood sugar, suppresses appetite, and makes you feel fuller faster

BRAF V600E mutations identify a unique subtype of metastatic non-small cell lung cancer that presents an actionable biomarker that precision medicines like [the Braftovi/ Mektovi] combination therapy can help address, said Gregory Riely, vice chair of clinical research in the Department of Medicine at Memorial Sloan Kettering Cancer Center and a PHAROS investigator, in a prepared statement

Through GLP-1 receptor activation, patients experience decreased food cravings, slower gastric emptying, and improved metabolic function, with clinical trials demonstrating these benefits across diverse populations, ultimately enabling long-term weight management success

15, we revisited the topic of these drugs and their meteoric rise in popularity